Systemic chemo-immunotherapy for advanced-stage hepatocellular carcinoma. - Wikidata - awgldk - TriplyDB

Systemic chemo-immunotherapy for advanced-stage hepatocellular carcinoma.

Systemic chemo-immunotherapy for advanced-stage hepatocellular carcinoma.

http://www.wikidata.org/entity/Q35010248

about

Potentiality of immunotherapy against hepatocellular carcinoma Advantages of a unique DNA-based vaccine in comparison to paclitaxel in treatment of an established intracerebral breast cancer in mice.Combined intra-arterial 5-fluorouracil and subcutaneous interferon-alpha therapy for highly advanced hepatocellular carcinoma.Modified cisplatin/interferon α-2b/doxorubicin/5-fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability, and survival of initially unresectable hepatocellular carcinoma Translational medicine in hepatocellular carcinoma.PPAR-gamma Thiazolidinedione Agonists and Immunotherapy in the Treatment of Brain Tumors.Antiproliferation and apoptosis induction of paeonol in HepG2 cells.Adjuvant intraportal venous chemotherapy for patients with hepatocellular carcinoma and portal vein tumor thrombi following hepatectomy plus portal thrombectomy.

P2860

Q26784228-F36F2C2A-3917-48C9-B1D6-069D882C897C Q34977081-48BA45B8-CA9E-4680-894F-244F32DD8C9B Q36945072-E61DA44E-CEE8-4F16-81D6-8FBE874B5CB4 Q37179530-6D49AA3D-87C2-42CB-836A-EF5BFCCBC06E Q38008950-DD4B3FA4-CACA-49A5-9B2C-0DFC7963B753 Q38620031-3EFADC18-168A-46A5-A91D-6C162360DDAA Q40182721-EE471BE5-4802-4B1F-B196-82A86647BE9F Q46785695-76DE0297-0552-4721-BE4C-B4B7B5C58162

P2860

Systemic chemo-immunotherapy for advanced-stage hepatocellular carcinoma.

http://www.wikidata.org/entity/Q35010248

description

2005 nî lūn-bûn

@nan

2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Systemic chemo-immunotherapy for advanced-stage hepatocellular carcinoma.

@ast

Systemic chemo-immunotherapy for advanced-stage hepatocellular carcinoma.

@en

type

label

Systemic chemo-immunotherapy for advanced-stage hepatocellular carcinoma.

@ast

Systemic chemo-immunotherapy for advanced-stage hepatocellular carcinoma.

@en

prefLabel

Systemic chemo-immunotherapy for advanced-stage hepatocellular carcinoma.

@ast

Systemic chemo-immunotherapy for advanced-stage hepatocellular carcinoma.

@en

P1433

Q35010248-6F578F9A-5554-4F72-8CE6-7B276997D833

P1476

Q35010248-F242D095-2C66-452A-872C-0C45ACD0F7B2

P2093

Q35010248-279BD0DC-2EEE-412D-BE69-B1C1D1C37175

Q35010248-8D09E032-1439-4620-A55E-EBE76E00ED4A

Q35010248-AB86CFB0-EA3B-4FCF-980A-02B27D21B508

Q35010248-B9B7F374-6484-4987-AD21-609440B5D026

Q35010248-DB50B3A1-EB9F-4B44-A56A-A5AF666DAE86

Q35010248-ECA50674-3873-41E0-B17D-6C2382E5515C

P2860

Q35010248-0399D7AE-802C-47F1-AA91-91F9B5562109

Q35010248-1382F829-675C-479F-B1DE-A39F3FAAEC5C

Q35010248-1DC77DB7-6D58-406E-B418-C6755483EA5B

Q35010248-2FD5274C-1702-4FFF-A6B0-A4CAA7DC9A93

Q35010248-53C22196-1A51-4AF9-8519-0746094BF8EC

Q35010248-5D319E35-6566-4C4D-9C7D-8C5A8801882F

Q35010248-628E492F-34F9-482D-8E4E-9B926D4E62E6

Q35010248-6441B4FC-9319-40B4-9432-6313D503A531

Q35010248-6C7DF4B4-7439-40A7-94DB-A8BE55549D9C

Q35010248-7FD1CFF8-83B2-4B32-AF2F-D9E26B6FFBCF

P304

Q35010248-7A424BCF-1FCE-4CFC-AB9F-ADE68645E398

P31

Q35010248-D9065AA0-34B1-45C1-8908-F3E2D47A0B57

P356

Q35010248-59E090C0-5E61-48CC-80F0-EBAF5AA5492C

P407

Q35010248-2620EFDA-A356-497F-A403-E0CB11D02152

P433

Q35010248-0E30CDBF-ED36-411C-A9D9-A1E46E9A561A

P478

Q35010248-6E5C0B7F-2DDC-47F0-893F-B2B13E59F4FD

P577

Q35010248-CC66CC7B-65BB-4FE5-9B4B-6A850989F21E

P5875

Q35010248-42F21678-118C-4EF0-9F55-500463AE75DB

P698

Q35010248-FD617793-A987-4AA5-954A-481BE1736A82

P921

Q35010248-73D8997D-B3B6-416F-BE8B-1273839036BF

P932

Q35010248-38F4EF1B-C821-4F99-BD33-CD661B2C320A

P356

WJG.V11.I16.2526

P1433

World Journal of Gastroenterology

P1476

Systemic chemo-immunotherapy for advanced-stage hepatocellular carcinoma.

@en

P2093

Dong-Ming Li

http://www.w3.org/2001/XMLSchema#string

Jia-Ming Lai

http://www.w3.org/2001/XMLSchema#string

Li-Jian Liang

http://www.w3.org/2001/XMLSchema#string

Ming Kuang

http://www.w3.org/2001/XMLSchema#string

Ming-De Lü

http://www.w3.org/2001/XMLSchema#string

Xiao-Yu Yin

http://www.w3.org/2001/XMLSchema#string

P2860

5-fluorouracil: mechanisms of action and clinical strategies

Preoperative systemic chemoimmunotherapy and sequential resection for unresectable hepatocellular carcinoma

Hepatocellular carcinoma

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective.

Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future.

Activity of interferon-alpha and isotretinoin in patients with advanced, refractory lymphoid malignancies.

Adjuvant interferon-alpha in malignant melanoma: current status.

P304

2526-2529

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V11.I16.2526

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2005-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273295532

http://www.w3.org/2001/XMLSchema#string

P698

15832431

http://www.w3.org/2001/XMLSchema#string

P921

P932

4305648

http://www.w3.org/2001/XMLSchema#string